Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: exosome-delivered neurological disorder therapeutics - EXO Biologics

Next Previous
X
Search
Drug Profile

Research programme: exosome-delivered neurological disorder therapeutics - EXO Biologics

Latest Information Update: 28 Jun 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator EXO Biologics
  • Class Exosome therapies
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Research Neurological disorders

Most Recent Events

  • 12 Jun 2024 EXO Biologics has patents pending for extracellular vesicles (EVs) derived from mesenchymal stromal cells and method for obtaining said EVs in Australia, Japan, Europe, Israel, Canada, South Korea, USA, China, Mexico, Brazil and worldwide
  • 12 Jun 2024 EXO Biologics has patents pending for extracellular vesicles and compositions thereof in USA, Europe and worldwide
  • 12 Jun 2024 EXO Biologics has patents pending for process for the manufacturing of protein-associated extracellular vesicles in Europe, Mexico, South Korea, Canada, Israel, Australia, China, USA, Japan, Brazil and worldwide

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top